Here are the top stories recently covered by DocWire News in the hematology/oncology section. In this edition, read several breast cancer updates, and more.
A study published online in the journal CANCER highlights factors that lead to racial disparities in deaths following prostate cancer surgery.
Researchers recently reported the results of the randomized, controlled phase 3 KEYNOTE-062 trial, which compared pembrolizumab, with or without chemotherapy, versus chemotherapy alone in patients with untreated, advanced gastric/gastroesophageal junction (G/GEJ) cancer. The researchers concluded that pembrolizumab, alone or in combination, was not inferior to chemotherapy.
Honeybee venom appears to rapidly destroy triple-negative breast cancer and HER2-enriched breast cancer cells, according to the findings of a study published in the journal Precision Oncology.
A study which appeared in the journal Oncotarget sheds light on why people with Down syndrome are at higher risk of leukemia. Researchers pinpointed a new set of genes overexpressed in endothelial cells of individuals with Down syndrome, thus creating an environment conducive for leukemia.
Among people with colorectal cancer who experience colorectal liver metastases, Blacks have the lowest survival outcomes of any race/ethnicity, according to a study published in JAMA Network Open.
Girls who hit puberty early have a significantly higher risk of developing breast cancer cells later in life, according to a study published in the Journal of Adolescent Health.